Recombinant UCHL1 antibody (full length)
Quick Overview for Recombinant UCHL1 antibody (full length) (ABIN7879277)
Target
See all UCHL1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Recombinant PGP9.5 Antibody (azide and preservative free)
-
Purification
- Protein A affinity chromatography
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the recombinant PGP9.5 antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the recombinant PGP9.5 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant PGP9.5 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))
-
Alternative Name
- PGP9.5
-
Background
- This MAb reacts with a protein of 20-30 kDa, identified as PGP9.5, also known as ubiquitin carboxyl-terminal hydrolase-1 (UchL1). Initially, PGP9.5 expression in normal tissues was reported in neurons and neuroendocrine cells but later it was found in distal renal tubular epithelium, spermatogonia, Leydig cells, oocytes, melanocytes, prostatic secretory epithelium, ejaculatory duct cells, epididymis, mammary epithelial cells, Merkel cells, and dermal fibroblasts. Furthermore, immunostaining for PGP9.5 has been shown in a wide variety of mesenchymal neoplasms as well. A mutation in PGP9.5 gene is believed to cause a form of Parkinsons disease.
-
UniProt
- P09936
-
Pathways
- Feeding Behaviour
Target
-